Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,36 EUR | +0,36% | +11,14% | +95,79% |
Omzet 2023 | 2,23 mln. 2,41 mln. | Omzet 2024 * | 37,83 mln. 41 mln. | Marktkapitalisatie | 181 mln. 196 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -23 mln. -24,92 mln. | Nettowinst (verlies) 2024 * | -5 mln. -5,42 mln. | EV/omzet 2023 | 36,2 x |
Nettoschuld 2023 * | 33,7 mln. 36,52 mln. | Nettoschuld 2024 * | 46,6 mln. 50,49 mln. | EV/omzet 2024 * | 6,01 x |
K/w-verhouding 2023 |
-3,63
x | K/w-verhouding 2024 * |
-19,4
x | Werknemers | 62 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 72,4% |
Recentste transcriptie over OSE Immunotherapeutics
1 dag | +0,60% | ||
1 week | +11,14% | ||
Lopende maand | +48,58% | ||
1 maand | +40,37% | ||
3 maanden | +157,85% | ||
6 maanden | +94,88% | ||
Lopend jaar | +95,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 69 | 17-11-04 | |
Nicolas Poirier
CEO | Chief Executive Officer | 42 | 31-05-16 |
Director of Finance/CFO | - | 01-05-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 69 | 17-11-04 | |
Director/Board Member | 66 | 22-06-23 | |
Director/Board Member | 66 | 18-02-22 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-05-24 | 8,36 | +0,36% | 116 092 |
22-05-24 | 8,33 | +14,74% | 781 168 |
21-05-24 | 7,26 | +0,97% | 77 296 |
20-05-24 | 7,19 | -2,97% | 162 104 |
17-05-24 | 7,41 | -1,72% | 212 142 |
Real Time Euronext Paris, 23 mei 2024 om 11:22 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+95,79% | 196 mln. | |
+64,23% | 62,59 mld. | |
-2,31% | 41,18 mld. | |
+45,55% | 40,29 mld. | |
-8,29% | 27,9 mld. | |
+11,97% | 26,21 mld. | |
-21,16% | 19,09 mld. | |
+7,54% | 13,08 mld. | |
+27,17% | 12,05 mld. | |
+25,72% | 12,26 mld. |